Trials / Not Yet Recruiting
Not Yet RecruitingNCT07273656
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 59 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the efficacy and safety of a combined approach of cryotherapy and tirbanibulin for the treatment of actinic keratosis of the scalp and forehead, repeated every 4 months. A higher rate of complete response is expected with this combination compared to cryotherapy alone, as well as a better response with repeated treatment cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cryotherapy + Tirbanibulin | Tirbanibulin ointment applied once daily for 5 days, repeated 3 times (every 4 months) |
Timeline
- Start date
- 2025-11-30
- Primary completion
- 2027-11-30
- Completion
- 2027-11-30
- First posted
- 2025-12-09
- Last updated
- 2025-12-09
Source: ClinicalTrials.gov record NCT07273656. Inclusion in this directory is not an endorsement.